Antithrombin-III as a Non-Invasive Marker of Chronic Liver Disease

AUTHORS

Mohammad Reza Sheikh Sajjadieh 1 , * , Lodmila Vasilovna Viunytska 2

1 Department of Clinical Laboratory Diagnosis, National Medical Academy for Postgraduate Education, [email protected], Ukraine

2 Department of Clinical Laboratory Diagnosis, National Medical Academy for Postgraduate Education, Ukraine

How to Cite: Sajjadieh M, Viunytska L. Antithrombin-III as a Non-Invasive Marker of Chronic Liver Disease, Hepat Mon. Online ahead of Print ; 9(2):128-132.

ARTICLE INFORMATION

Hepatitis Monthly: 9 (2); 128-132
Article Type: Research Article
Received: December 9, 2008
Accepted: May 7, 2009

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background and Aims: Recently, many studies have reported that the plasma concentrations of natural anticoagulants, such as Antithrombin-III (AT-III), are altered in patients with chronic liver disease. In addition, the changes in the synthesis of AT-III occur in liver tissue and are associated with the extent of chronic hepatitis and cirrhosis.

Methods: In this study, we analyzed the plasma level of ??-III and serum activity of aminotransferase in 60 participants: 20 patients with chronic hepatitis, 20 patients with cirrhosis, and 20 healthy individuals (controls).

Results: Low levels of AT-III and elevated levels of aminotransferase activity were associated with both chronic hepatitis and cirrhosis. We found that among patients with elevated gamma glutamyl transferase (GGT) activity and chronic liver disease, the level of ??-III in plasma was significantly lower in patients with chronic cirrhosis than in patients with chronic hepatitis (P < 0.05) and the level of ??-III in plasma was lower in patients with liver disease in comparison to healthy participants (P < 0.001).

Conclusions: The level of AT-III in patients with chronic liver disease may be used as a non-invasive factor for the laboratory diagnosis of cirrhosis.

Keywords

Chronic Liver Disease Antithrombin-III Hepatitis Cirrhosis

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: